Even if covered, your doctor may need to submit a prior authorization or proof that the drug is medically necessary
Notably, the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) trial, the first dedicated kidney outcome trial evaluating canagliflozin in people with type 2 diabetes mellitus and CKD, demonstrated a substantial reduction in the risk of kidney events [46]
Dias S, Sutton AJ, Ades AE, Welton NJ
Kidney testing should reflect diabetes, hypertension, chronic kidney disease, and dehydration risk
Gut-brain axis: GLP-1 is a peptide hormone (a small protein molecule) that is released in the upper part of the intestinal tract when you eat carbohydrates or certain proteins
For injectable GLP-1 medications currently in use , patients should be aware of common side effects including nausea, vomiting, diarrhea, and decreased appetite, particularly during dose escalation